Naveen Pemmaraju1, Audun Utengen2, Vikas Gupta3, Michael A Thompson4, Andrew A Lane5. 1. Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Unit 428, PO BOX 301402, Houston, TX, 77230-1402, USA. npemmaraju@mdanderson.org. 2. Symplur LLC, Los Angeles, CA, USA. 3. The Elizabeth and Tony Comper MPN Program, Princess Margaret Cancer Center, Toronto, ON, Canada. 4. Advocate Aurora Health, Aurora Research Institute, Milwaukee, WI, USA. 5. Dana-Farber Cancer Institute, Boston, MA, USA.
Abstract
PURPOSE OF REVIEW: Engagement on social media for professional, healthcare-related communication is rapidly rising around the world. We aimed to better understand the dynamics of a rare disease Twitter hashtag community. RECENT FINDINGS: Twitter has served as a platform for academic discussion, a method for knowledge dissemination directly from medical meetings, and a venue for patient caregiver and support groups. One example of a rare cancer that has seen an increase in available information via Twitter is blastic plasmacytoid dendritic cell neoplasm, or BPDCN. This field has recently experienced a new wave of interest from various healthcare stakeholders in light of key new scientific breakthroughs and novel clinical trials now starting to be available. In order to bring all relevant healthcare stakeholders together, the investigators of this article created a disease-specific Twitter community: #BPDCN = "blastic plasmacytoid dendritic cell neoplasm on social media" which has led to higher levels of engagement and discussion in the field. This article focuses on our analysis of advanced Twitter user-metrics in the second year of #BPDCN and discusses future directions for this rare cancer online disease community.
PURPOSE OF REVIEW: Engagement on social media for professional, healthcare-related communication is rapidly rising around the world. We aimed to better understand the dynamics of a rare disease Twitter hashtag community. RECENT FINDINGS: Twitter has served as a platform for academic discussion, a method for knowledge dissemination directly from medical meetings, and a venue for patient caregiver and support groups. One example of a rare cancer that has seen an increase in available information via Twitter is blastic plasmacytoid dendritic cell neoplasm, or BPDCN. This field has recently experienced a new wave of interest from various healthcare stakeholders in light of key new scientific breakthroughs and novel clinical trials now starting to be available. In order to bring all relevant healthcare stakeholders together, the investigators of this article created a disease-specific Twitter community: #BPDCN = "blastic plasmacytoid dendritic cell neoplasm on social media" which has led to higher levels of engagement and discussion in the field. This article focuses on our analysis of advanced Twitter user-metrics in the second year of #BPDCN and discusses future directions for this rare cancer online disease community.
Authors: Naveen Pemmaraju; Audun Utengen; Vikas Gupta; Michael A Thompson; Andrew A Lane Journal: Curr Hematol Malig Rep Date: 2017-12 Impact factor: 3.952
Authors: Uday Deotare; Karen W L Yee; Lisa W Le; Anna Porwit; Anne Tierens; Rumina Musani; David Barth; Emina Torlakovic; Aaron Schimmer; Andre C Schuh; Matthew Seftel; Mark D Minden; Vikas Gupta; Elizabeth Hyjek Journal: Am J Hematol Date: 2016-01-11 Impact factor: 10.047
Authors: Damien Roos-Weil; Sascha Dietrich; Ariane Boumendil; Emmanuelle Polge; Dominique Bron; Enric Carreras; Arturo Iriondo Atienza; William Arcese; Dietrich W Beelen; Jan J Cornelissen; Nicolaus Kröger; Giuseppe Milone; Giuseppe Rossi; Fabrice Jardin; Christina Peters; Vanderson Rocha; Anna Sureda; Mohamad Mohty; Peter Dreger Journal: Blood Date: 2012-11-30 Impact factor: 22.113
Authors: Michael A Thompson; Navneet S Majhail; William A Wood; Miguel-Angel Perales; Mélanie Chaboissier Journal: Curr Hematol Malig Rep Date: 2015-12 Impact factor: 3.952
Authors: Khaled Alayed; Keyur P Patel; Sergej Konoplev; Rajesh R Singh; Mark J Routbort; Neelima Reddy; Naveen Pemmaraju; Liping Zhang; Abdulaziz Al Shaikh; Tariq N Aladily; Nitin Jain; Rajyalakshmi Luthra; L Jeffrey Medeiros; Joseph D Khoury Journal: Am J Hematol Date: 2013-09-30 Impact factor: 10.047
Authors: Justin Taylor; Michael Haddadin; Vivek A Upadhyay; Erwin Grussie; Neha Mehta-Shah; Andrew M Brunner; Abner Louissaint; Scott B Lovitch; Ahmet Dogan; Amir T Fathi; Richard M Stone; Martin S Tallman; Raajit K Rampal; Donna S Neuberg; Kristen E Stevenson; Steven M Horwitz; Andrew A Lane Journal: Blood Date: 2019-06-26 Impact factor: 22.113
Authors: Emily G Miller; Amanda L Woodward; Grace Flinchum; Jennifer L Young; Holly K Tabor; Meghan C Halley Journal: Genet Med Date: 2021-07-19 Impact factor: 8.864
Authors: Siba El Hussein; Joseph D Khoury; Kirill A Lyapichev; Mehrnoosh Tashakori; Mahsa Khanlari; Roberto N Miranda; Rashmi Kanagal-Shamanna; Sa A Wang; Aadil Ahmed; Kamran M Mirza; Genevieve M Crane; L Jeffrey Medeiros; Sanam Loghavi Journal: Mod Pathol Date: 2020-11-20 Impact factor: 7.842